Vulvovaginal Candidiasis in Pregnant Women Attending the Garoua Regional Hospital (Cameroon) and Antifungals Susceptibility Profile of Isolates

Full Article PDF Review History

Published: 2023-07-24

Page: 151-159

Isaac Mboh Eyong

Department of Obstetrics and Gynaecology, Faculty of Health Sciences, University of Buea, Cameroon.

Yves Somo Iwewe *

Department of Biomedical Sciences, Faculty of Science, University of Ngaoundere, Cameroon.

Tameh Theodore Yangsi

Department of Clinical Sciences, Faculty of Health Sciences, University of Bamenda, Cameroon.

Ali Abas

Department of Traditional Medicine and Pharmacopoeia, Faculty of Medicine and Biomedical Sciences, University of Garoua, Cameroon.

Fabrice Ndeguena Katoua

Department of Biomedical Sciences, Higher Institute of Sciences, Health Techniques and Management, University of Garoua, Cameroon.

Theophile Nana Njamen

Department of Obstetrics and Gynaecology, Faculty of Health Sciences, University of Buea, Cameroon.

*Author to whom correspondence should be addressed.


Background: Both vaginal colonization and infection by yeast (a type of fungus) are most likely to occur in Pregnant women. Considering this fact and owing to the lack of data on this subject in North Cameroon, the main objective of this study was to determine the prevalence of vulvovaginal candidiasis (VVC) in pregnant women at the Garoua Regional Hospital and the susceptibility of isolates to some commonly used antifungal agents.

Methods: We conducted a cross-sectional study during a period of 6 months (January to June 2023) at the Regional Hospital of Garoua. A total of 282 vaginal swabs collected were cultured on ChromAgar Candida medium for isolation and identification of the Candida species. The microdilution technique was used for the susceptibility testing of the isolates.

Results: Mycological examination revealed that, out of 282 vaginal swab samples collected, 78 (27.65%) were positive for Candida spp culture. The identification of yeast isolates showed that only two Candida species were involved in VVC in the studied population. Candida albicans was the major species with 71.79%) and Candida krusei was 28.20%. The most affected age groups were those of [26-30] and [31-35] with 35.9% each. Abundant leucorrhoea (69.23%) and pruritus (66.67%) were the most common symptoms in pregnant women with VVC. Wearing tight clothes and being under antibiotic treatment were the most prominent risk factors associated with VVC among the study participants. Candida albicans showed 100% resistance towards nystatin and amphotericin B while the highest of Candida krusei was observed with itraconazole (72.41%) and amphotericin b (96.55%). Both species showed sensitivity towards miconazole and econazole.

Conclusion: The present study has revealed that the prevalence of vulvovaginal candidiasis cases among pregnant women at the Garoua Regional Hospital is 27.65%. Only C. albicans and C. krusei were involved in VVC in the studied population. The antifungal susceptibility profile confirmed the efficacy of econazole and miconazole for the treatment.

Keywords: Vulvovaginal candidiasis, pregnant woman, Candida species

How to Cite

Eyong , I. M., Iwewe , Y. S., Yangsi , T. T., Abas , A., Katoua , F. N., & Njamen , T. N. (2023). Vulvovaginal Candidiasis in Pregnant Women Attending the Garoua Regional Hospital (Cameroon) and Antifungals Susceptibility Profile of Isolates. Asian Research Journal of Gynaecology and Obstetrics, 6(1), 151–159. Retrieved from


Nyirjesy P, Brookhart C, Lazenby G, Schwebke J, Sobel JD. Vulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines. Clinical Infectious Diseases. 2022;74.

Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. The Lancet Infectious Diseases. 2018;18.

Doumbo SN, Cissoko Y, Dama S, Niangaly A, Garango A, Konaté A, et al. The estimated burden of fungal diseases in Mali. Journal of Medical Mycology. 2023; 33.

Yan L, Wang XD, Seyedmousavi S, Yuan JN, Abulize P, Pan WH, Yu N, Yang YL, Hu HQ, Liao WQ, Deng SW. Antifungal Susceptibility Profile of Candida albicans Isolated from Vulvovaginal Candidiasis in Xinjiang Province of China. Mycopathologia. 2019;184.

Disha T, Haque F. Prevalence and Risk Factors of Vulvovaginal Candidosis during Pregnancy: A Review. Infectious Diseases in Obstetrics and Gynecology. 2022;2022.

Aguin TJ, Sobel JD. Vulvovaginal Candidiasis in Pregnancy. Current Infectious Disease Reports. 2015;17.

Gangakhedkar GR, Kulkarni AP. Physiological Changes in Pregnancy. Indian J Crit Care Med. 2021;25.

Mor G, Cardenas I. The Immune System in Pregnancy: A Unique Complexity. American Journal of Reproductive Immunology. 2010;63.

Michael OI, Gabriel IM, Olayinka OO, Matthew AA, Olajide AA. Prevalence of vulvo-vaginal candidiasis among women attending clinics in selected Hospitals in Oyo State, Southwest, Nigeria. J Public Heal Epidemiol. 2022;14:45–52.

Bitew A, Abebaw Y. Vulvovaginal candidiasis: Species distribution of Candida and their antifungal susceptibility pattern. BMC Womens Health. 2018;18.

Sdoudi K, El Hamoumi R, Chaïb N, El Mdaghri N, Razki A. Candidoses vaginales a Casablanca: implication des espèces non albicans et particularités étiologiques. Eur Sci Journal, ESJ. 2014;10:167–82.

Toua V, Djaouda M, Gaké B, Menye DE, Akoachere E, Tambe E, Akindoh VV, Njiné T. Prevalence of Vulvovaginal Candidiasis amongst pregnant women in Maroua ( Cameroon ) and the sensitivity of Candida albicans to extracts of six locally used antifungal plants. 2013;4 March:89–97.

Kechia FA, Dohbit JS, Kouotou EA, Iwewe SY, Dzoyem JP, Mbopuwouo NM, Moyou SR. Profil Épidémiologique et Étiologique de la Candidose Vulvo-Vaginale chez la Femme Enceinte à Yaoundé (Cameroun). Heal Sci Dis. 2015;16:1–6.

Quindós G, Marcos-Arias C, San-Millán R, Mateo E, Eraso E. The continuous changes in the aetiology and epidemiology of invasive candidiasis: from familiar Candida albicans to multiresistant Candida auris. International Microbiology. 2018;21.

Bouchara J-P, Phiet M, De Gentile L, Cimon B CD. Les levures et les levuroses. 2010.

Hudzicki J. Kirby-Bauer Disk Diffusion Susceptibility Test Protocol Author Information. Am Soc Microbiol. 2012; December 2009.

Sharma A. Vulvo Vaginal Candidiasis: Prevalence and Risk in Pregnancy. ECS Trans. 2022;107.

Patowary MB, Kakoly IJ. Impact of Socio-demographic Determinants on Individual Health in Bangladesh. J Soc Sci Res. 2023. Available:

Jalali-Farahani S, Amiri P, Bakht S, Shayeghian Z, Cheraghi L, Azizi F. Socio-demographic determinants of health-related quality of life in Tehran Lipid and Glucose Study (TLGS). Int J Endocrinol Metab. 2017;15.

Salvi M. Prevalence of vulvovaginal candidiasis in females in the reproductive age group. Int J Reprod Contraception, Obstet Gynecol. 2019;8.

Kiasat N, Rezaei-Matehkolaei A, Mahmoudabadi AZ, Mohamadpour KH, Molavi S, Khoshayand N. Prevalence of vulvovaginal candidiasis in ahvaz, Southwest Iran: A Semi-Large scale study. Jundishapur J Microbiol. 2019;12.

Waikhom SD, Afeke I, Kwawu GS, Mbroh HK, Osei GY, Louis B, Deku JG, Kasu ES, Mensah P, Agede CY, Dodoo C, Asiamah EA, Tampuori J, Korbuvi J, Opintan JA. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: Species identification and antifungal susceptibility of Candida isolates. BMC Pregnancy Childbirth. 2020;20.

Edrees WH, Al-Asbahi AA, Al-Shehari WA, Qasem EA. Vulvovaginal candidiasis prevalence among pregnant women in different hospitals in IBB, Yemen. Univers J Pharm Res. 2020.


Abdullahi Nasir I, Uchenna E, Onyia J, Ifunanya AL. Prevalence of vulvovaginal candidiasis among nonpregnant women attending a tertiary health care facility in Abuja, Nigeria. Res Rep Trop Med; 2015.


Kumwenda P, Cottier F, Hendry AC, Kneafsey D, Keevan B, Gallagher H, Tsai HJ, Hall RA. Estrogen promotes innate immune evasion of Candida albicans through inactivation of the alternative complement system. Cell Rep. 2022;38.

Sangaré I, Sirima C, Bamba S, Zida A, Cissé M, Bazié WW, Sanou S, Dao B, Menan H, Guiguemdé RT. Prevalence of vulvovaginal candidiasis in pregnancy at three health centers in Burkina Faso. J Mycol Med. 2018;28.

Willems HME, Ahmed SS, Liu J, Xu Z, Peters BM. Vulvovaginal candidiasis: A current understanding and burning questions. Journal of Fungi. 2020;6.

Güzel AB, Aydin M, Meral M, Kalkanci A, Ilkit M. Clinical characteristics of Turkish women with Candida krusei vaginitis and antifungal susceptibility of the C. krusei isolates. Infect Dis Obstet Gynecol. 2013;2013.

Khadka S, Sherchand JB, Pokhrel BM, Parajuli K, Mishra SK, Sharma S, Shah N, Kattel HP, Dhital S, Khatiwada S, Parajuli N, Pradhan M, Rijal BP. Isolation, speciation and antifungal susceptibility testing of Candida isolates from various clinical specimens at a tertiary care hospital, Nepal. BMC Res Notes. 2017;10.

Anas Wisam Malik, Ahmed Kamil Awad, Hayder T Qaddoori. Candida species associated with urinary tract infections. World J Adv Res Rev. 2022;16.